Zacks Investment Research
TRUP Lags Industry, Trades at a Premium: What Should Investors Know?
Trupanion (TRUP) shares have declined 36.5% year-to-date due to rising veterinary costs, slower pet growth, and underwriting pressure. While the company operates in a large, underpenetrated pet insurance market with strong growth prospects and international expansion opportunities, its premium valuation and muted analyst sentiment warrant a cautious wait-and-see approach. The company projects 2026 revenues of $1.584-$1.601B with 14% YoY growth.
